What conditions does sertraline hydrochloride tablets treat?
Sertraline Hydrochloride Tablets are antidepressants. They are indicated for the treatment of depressive symptoms, including depression accompanied by anxiety, and depression with or without a history of mania. After achieving satisfactory therapeutic response, continued administration of sertraline hydrochloride tablets effectively prevents relapse of depression. Additionally, they are also approved for the treatment of obsessive-compulsive disorder (OCD). Below is a detailed overview of the clinical indications for sertraline hydrochloride tablets.

What Conditions Does Sertraline Hydrochloride Tablet Treat?
1. Treatment of Depression
Sertraline hydrochloride is an antidepressant primarily used to treat depressive disorders and associated symptoms—including anxiety and depression with or without a history of mania. If treatment yields favorable results, continued use of sertraline hydrochloride tablets can effectively prevent recurrence or relapse of depression. Importantly, sertraline hydrochloride must be used under medical supervision; self-medication may lead to adverse reactions, incomplete therapeutic response, or suboptimal efficacy.
2. Treatment of Obsessive-Compulsive Disorder (OCD)
Sertraline hydrochloride tablets are also indicated for OCD. With satisfactory clinical response, continued therapy helps prevent recurrence of initial OCD symptoms. Furthermore, sertraline hydrochloride may be considered in the management of erectile dysfunction (ED); however, patients requiring ED treatment must undergo thorough evaluation under physician guidance to identify underlying causes. It is strongly recommended that such treatment be conducted only under professional medical supervision.

Additional Information: Important Precautions When Using Sertraline Hydrochloride Tablets
1. Dosage Management
When discontinuing sertraline hydrochloride, dosage reduction should be gradual to minimize potential withdrawal symptoms or symptom exacerbation. Abrupt cessation is not recommended. Additionally, some patients may experience significant weight loss during treatment.
2. Monitoring of Hematologic Parameters
Treatment with sertraline hydrochloride may increase fracture risk and is associated with platelet abnormalities and bleeding tendencies. Patients should be monitored for signs such as gingival bleeding or melena (black, tarry stools). Prompt medical evaluation is advised if any of these symptoms occur.

3. Close Observation of Patient Status
As sertraline hydrochloride is used to treat conditions such as anxiety and depression, patients may experience worsening of psychiatric symptoms—including increased suicidal ideation—especially early in treatment or following dose adjustments. In pre-marketing clinical trials, approximately 0.4% of patients treated with sertraline developed hypomania or mania.
The above outlines the primary indications for sertraline hydrochloride tablets. We hope this information is helpful to you.